200 Cardinal Way, 3rd Floor
Redwood City, CA 94063
9 articles with Genapsys
Innocoll Biotherapeutics, Genapsys, and Adicet Bio announced today their relocation and expansion plans.
Genapsys, Inc. today announced the additions of Priya Ray and Peter Swider to the Company's leadership team as well as the launch of the company's new branding and corporate website, www.genapsys.com .
GenapSys, Inc. today announced the appointment of Ryan Walters , Ph.D. as Chief Product Officer.
GenapSys, Inc. today announced the addition of Dana Moss to the Company's executive team, and further expanded the Company's leadership team with the addition of Aric Ledford , and Richard Lyon .
GenapSys, Inc. today announced the additions of Britton Russell , Mary Stewart , and Surekha Karudapuram to its executive team.
GenapSys, Inc. today announced the appointment of Fredrik Eliasson , Diana McKenzie , and Loretta Cecil to its Board of Directors.
Capital will enable continued advancement of GenapSys' electronic-based, next-generation sequencing platform
GenapSys Inc. (GenapSys), the company behind the world’s first highly accurate, affordable, and accessible gene sequencer, today announced it has named Jason Myers as its Chief Executive Officer, effective February 15, 2021
GenapSys Partners With Twist Bioscience to Bring Next-Generation Sequencing Target Enrichment and Library Preparation to World’s Most Accessible Highly Accurate Sequencer
GenapSys Inc., the company behind the world’s first highly accurate, affordable, and portable gene sequencer, today announced a new OEM partnership with Twist Bioscience, a company enabling customers to succeed through its offering of high-quality synthetic DNA.